$447 Million is the total value of SECTOR GAMMA AS's 29 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 38.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | GILEAD SCIENCES INC | $46,347,355 | +2.9% | 601,367 | +10.8% | 10.37% | -5.0% |
| CAH | Buy | CARDINAL HEALTH INC | $36,375,594 | +27.9% | 384,642 | +2.1% | 8.14% | +18.0% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $32,459,485 | +4.2% | 507,576 | +12.9% | 7.26% | -3.9% |
| MDT | Buy | MEDTRONIC PLC | $30,527,355 | +18.7% | 346,508 | +8.7% | 6.83% | +9.6% |
| BIIB | Buy | BIOGEN INC | $27,276,381 | +11.7% | 95,757 | +9.0% | 6.10% | +3.1% |
| INCY | Sell | INCYTE CORP | $24,746,367 | -20.8% | 397,532 | -8.0% | 5.54% | -26.9% |
| BDX | New | BECTON DICKINSON & CO | $24,532,601 | – | 92,923 | +100.0% | 5.49% | – |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $21,667,027 | -4.8% | 148,812 | -15.5% | 4.85% | -12.1% |
| BAX | Buy | BAXTER INTL INC | $21,578,765 | +218.6% | 473,634 | +183.6% | 4.83% | +194.0% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $18,421,800 | +40.2% | 195,291 | +23.0% | 4.12% | +29.4% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $17,642,188 | -5.5% | 73,104 | -10.2% | 3.95% | -12.8% |
| CNC | Buy | CENTENE CORP DEL | $16,521,810 | +9.5% | 244,949 | +2.6% | 3.70% | +1.0% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $14,100,062 | -7.3% | 162,668 | +4.0% | 3.16% | -14.4% |
| ANTM | Sell | ELEVANCE HEALTH INC | $13,928,936 | -15.3% | 31,351 | -12.4% | 3.12% | -21.8% |
| THC | Sell | TENET HEALTHCARE CORP | $13,139,371 | +33.8% | 161,457 | -2.3% | 2.94% | +23.5% |
| New | GE HEALTHCARE TECHNOLOGIES I | $12,293,887 | – | 151,328 | +100.0% | 2.75% | – | |
| NUVA | Buy | NUVASIVE INC | $11,078,328 | +14.7% | 266,370 | +14.0% | 2.48% | +5.9% |
| BRKR | Sell | BRUKER CORP | $8,296,929 | -31.3% | 112,242 | -26.7% | 1.86% | -36.6% |
| CTLT | Buy | CATALENT INC | $7,808,616 | -21.0% | 180,088 | +19.7% | 1.75% | -27.1% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $6,581,253 | +25.7% | 160,401 | +9.5% | 1.47% | +16.1% |
| AMED | New | AMEDISYS INC | $6,492,880 | – | 71,007 | +100.0% | 1.45% | – |
| QGEN | Sell | QIAGEN NV | $5,742,496 | -52.1% | 127,526 | -51.1% | 1.28% | -55.8% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $5,331,046 | -2.8% | 28,067 | +2.5% | 1.19% | -10.3% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $4,806,669 | +9.7% | 200,696 | -13.8% | 1.08% | +1.2% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $4,640,909 | +8.9% | 100,605 | -5.3% | 1.04% | +0.5% |
| JNJ | New | JOHNSON & JOHNSON | $4,381,480 | – | 26,471 | +100.0% | 0.98% | – |
| LNTH | New | LANTHEUS HLDGS INC | $4,221,931 | – | 50,309 | +100.0% | 0.94% | – |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $3,689,459 | +8.9% | 150,406 | +3.3% | 0.83% | +0.6% |
| PTCT | Buy | PTC THERAPEUTICS INC | $2,300,987 | -13.5% | 56,577 | +3.0% | 0.52% | -20.2% |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -38,310 | -100.0% | -0.69% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -26,554 | -100.0% | -0.80% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -23,677 | -100.0% | -1.34% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -56,153 | -100.0% | -1.45% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -13,617 | -100.0% | -1.58% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -36,000 | -100.0% | -1.77% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -162,397 | -100.0% | -1.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.